Criteria for Membership

Consortium membership is available to faculty based at Consortium institutions whose work is cancer-focused. Members have access to exclusive research networks, resources, and funding sources offered by the Consortium. Additionally, members have the opportunity to expand their leadership potential by assuming roles and responsibilities within the Consortium, as appropriate.

Assistant-level faculty planning to conduct cancer research may apply at the time of their faculty appointment, provided they have published on cancer-related topics in their respective field. It is expected these individuals will meet the remaining eligibility requirements within four years of becoming a member.

Membership Benefits

Consortium members have access to a variety of resources and opportunities, including:

Responsibilities

Members are expected to participate in supporting the Consortium in the following ways:

  • Serving on Consortium committees, including the Scientific Review Committee and Developmental Funds Review Committee, depending on your area(s) of expertise matching committee needs. (Anticipated cadence for service on a committee that meets monthly would be a 3-year term approximately every 10 years or so.)
  • Citing the CCSG, especially when Consortium Shared Resources or Clinical Research Support services are used in the course of your research, or if your research is directly funded by a CCSG-funded award or supplement.
  • Following all clinical research policies as outlined by Clinical Research Support.

Eligibility

Members must have:

  1. An assistant-level or higher faculty appointment at one of the Consortium institutions, and
  2. Contributed to the peer-reviewed cancer literature within the past 3 years, and
  3. Meet one or more of the following:
  • Obtained extramural cancer-relevant peer-reviewed grant support as a Principal Investigator (PI), Co-PI, or Co-Investigator, or received substantial effort from peer-reviewed funding within the past 4 years
  • Played a leadership role in Consortium-sponsored interventional cancer clinical trials within the last 2 years through protocol development, implementation, patient accrual, and publication co-authorship; includes an on-going commitment to ensuring clinical research staff are trained appropriately to fulfill their roles and responsibilities
  • Provided specialized medical, scientific, or administrative expertise to the overall research mission of the Consortium
  • Obtained membership per the Consortium director's discretion

Affiliate Membership

Clinical investigators who participate in Consortium-sponsored cancer-focused clinical trials and researchers who use the Consortium IRB for cancer-focused studies and do not meet the criteria for membership are welcome to apply for affiliate membership.

Affiliate Benefits

Affiliate Responsibilities

  • Citing the CCSG, especially when Consortium Shared Resources or Clinical Research Support services are used in the course of your research, or if your research is directly funded by a CCSG-funded award or supplement.

How to Apply

Complete and submit a membership application form; select "Clinical Trial Affiliate" from the application's research program drop-down; and attach a current NIH biosketch or CV.

Apply For Membership

How To Apply

  • Complete and submit a membership application; select a Consortium Research Program to join that best aligns with your research area (an “Other Oncology” option is available for research focuses that do not fit clearly within one of the listed research programs)
  • Attach a current NIH biosketch or CV

Processing

Applications are accepted on a rolling basis and are typically processed within 7 business days. Formal acknowledgement of your membership will be provided once your application is approved.

Membership Audits

Membership is audited regularly for eligibility. Members are contacted informing them of pending inactivation if:
 
  • Their appointment is no longer at least assistant-level professor
  • Evidence of cancer-relevant work such as extramural funding, trials, and/or publications cannot be identified within the last three years

Members will have the opportunity to provide clarification through this process.